For the First Time, Researchers Eliminated HIV From the Genomes of Living Animals
By Alice Park,
Time
| 07. 02. 2019
There’s no question that powerful anti-HIV medications can do a fairly good job of keeping the virus under control. Used properly, these anti-retroviral drugs (ARVs) can suppress HIV enough to keep it at levels so low they’re undetectable in the blood, which drastically lowers the chance of spreading the virus during sexual activity or transfusions. But ARVs can only do so much.
They work best on viruses that are actively making copies of themselves and infecting healthy cells. HIV has evolved to “learn” this, and can mutate to become resistant to the medications so that as soon as the drug onslaught stops, viruses replicate with abandon once again. HIV can also preserve itself by hiding, quiescent and not replicating, in lymph and other tissues throughout the body. When the immune system drops its guard, these latent viruses can start replicating again. All of which means that once a person is infected, these viruses remain in the body like an uncapped grenade, just waiting to overwhelm the immune system with millions of infectious virus, years, or even decades, after HIV infected...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...